Literature DB >> 29743801

Acute Exacerbation to Autoimmune Hepatitis Mimicking Acute Viral Hepatitis-A Case Series and Review of Literature.

Sunil Taneja1, Pramod Kumar1, Suvradeep Mitra2, Ajay Duseja1, Ranjana Minz3, Ashim Das2, Radha K Dhiman1, Yogesh Chawla1.   

Abstract

BACKGROUND: Acute exacerbation of Autoimmune Hepatitis (AIH) poses a significant challenge for diagnosis as it can mimic acute viral hepatitis especially in absence of autoantibodies and hypergammaglobulinemia. AIM: To determine the clinical, laboratory, histopathological characteristics and response to treatment in AIH patients with acute exacerbation.
METHODS: A retrospective analysis of 16 patients with acute exacerbation of AIH diagnosed over a period of eight years (2008-2016).
RESULTS: Out of the 111 patients diagnosed with AIH, acute exacerbation of AIH was diagnosed in 16 (14.4%) patients. All patients were females with median age of 35 years. Nine patients (56%) had Type 1 AIH and seven (44%) patients were diagnosed with seronegative AIH. All 16 (100%) patients had acute viral hepatitis like illness at presentation. The median bilirubin was 4.2 mg/dl (range, 2.2-20), aspartate transaminase was 568 IU/L (range, 390-908), alanine transaminase was 430 IU/L (range, 257-1026) and serum alkaline phosphatase was 395 IU/L (range, 112-890) during symptomatic period. The histopathological examination showed underlying chronic hepatitis in 10 (71.4%) patients, only fibrosis in 2 (14.2) patients and cirrhosis with activity in 2 (14.2%). All 16 (100%) patients were treated with a combination of steroids and azathioprine. Thirteen (81%) patients achieved complete biochemical remission and three (19%) patients achieved partial remission out of which one (6%) patient succumbed to illness because of the complications of cirrhosis.
CONCLUSION: A suspicion of acute exacerbation of AIH should be considered in patients with unexplained acute hepatitis mimicking acute viral hepatitis in the absence of positive viral markers. Through evaluation with immunoserological markers and liver biopsy can clinch the diagnosis of acute exacerbation of AIH in such cases.

Entities:  

Keywords:  AASLD, American Association of Study of Liver; AIH, Autoimmune Hepatitis; ALKM-1, Liver/Kidney Microsomes; ALT, Alanine Transaminase; AMA, Antimitochondrial Antibody; ANA, Antinuclear Antibodies; ANCA, Anti-neutrophil Cytoplasmic Antibody; ASMA, Anti-smooth Muscle Antibodies; AST, Aspartate Transaminase; CBR, Complete Biochemical Response; CT, Computed Tomography; ELISA, Enzyme-linked Immunosorbent Assay; IAIHG, International Autoimmune Hepatitis Group; IIF, Indirect Immunofluorescence; INR, International Normalized Ratio; MRCP, Magnetic Response Cholangiopancreatography; PBC, Primary Biliary Cirrhosis; PBR, Partial Biochemical Response; PSC, Primary Sclerosing Cholangitis; SAP, Serum Alkaline Phosphatase; acute exacerbation; autoimmune hepatitis; primary biliary cirrhosis; primary sclerosing cholangitis

Year:  2017        PMID: 29743801      PMCID: PMC5938335          DOI: 10.1016/j.jceh.2017.08.005

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  34 in total

1.  Diagnosis and management of autoimmune hepatitis.

Authors:  Michael P Manns; Albert J Czaja; James D Gorham; Edward L Krawitt; Giorgina Mieli-Vergani; Diego Vergani; John M Vierling
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

2.  EASL Clinical Practice Guidelines: Autoimmune hepatitis.

Authors: 
Journal:  J Hepatol       Date:  2015-09-01       Impact factor: 25.083

Review 3.  Autoimmune hepatitis.

Authors:  Edward L Krawitt
Journal:  N Engl J Med       Date:  2006-01-05       Impact factor: 91.245

Review 4.  Autoimmune hepatitis--Update 2015.

Authors:  Michael P Manns; Ansgar W Lohse; Diego Vergani
Journal:  J Hepatol       Date:  2015-04       Impact factor: 25.083

5.  Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands.

Authors:  Nicole M F van Gerven; Bart J Verwer; Birgit I Witte; Karel J van Erpecum; Henk R van Buuren; Ingrid Maijers; Arjan P Visscher; Edwin C Verschuren; Bart van Hoek; Minneke J Coenraad; Ulrich H W Beuers; Robert A de Man; Joost P H Drenth; Jannie W den Ouden; Robert C Verdonk; Ger H Koek; Johannes T Brouwer; Maureen M J Guichelaar; Jan Maarten Vrolijk; Chris J J Mulder; Carin M J van Nieuwkerk; Gerd Bouma
Journal:  Scand J Gastroenterol       Date:  2014-08-15       Impact factor: 2.423

6.  Proposal of autoimmune hepatitis presenting with acute hepatitis, severe hepatitis and acute liver failure.

Authors:  Morikazu Onji
Journal:  Hepatol Res       Date:  2011-05-06       Impact factor: 4.288

7.  Present status of autoimmune hepatitis in Japan: a nationwide survey.

Authors:  Masanori Abe; Toshie Mashiba; Mikio Zeniya; Kazuhide Yamamoto; Morikazu Onji; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2011-05-20       Impact factor: 7.527

8.  Acute presentation of autoimmune hepatitis: Does it exist? A published work review.

Authors:  Hiroki Takahashi; Mikio Zeniya
Journal:  Hepatol Res       Date:  2011-05-19       Impact factor: 4.288

9.  Centrilobular necrosis in acute presentation of Japanese patients with type 1 autoimmune hepatitis.

Authors:  Kazumichi Abe; Yukiko Kanno; Ken Okai; Fumiko Katsushima; Kyoko Monoe; Hironobu Saito; Atsushi Takahashi; Junko Yokokawa; Hiromasa Ohira
Journal:  World J Hepatol       Date:  2012-09-27

10.  Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study.

Authors:  Mårten Werner; Hanne Prytz; Bodil Ohlsson; Sven Almer; Einar Björnsson; Annika Bergquist; Sven Wallerstedt; Hanna Sandberg-Gertzén; Rolf Hultcrantz; Per Sangfelt; Ola Weiland; Ake Danielsson
Journal:  Scand J Gastroenterol       Date:  2008       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.